CoChat
Sign Up
Cited by 6

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Stem Cell-Derived Exosomal MicroRNAs as Novel Potential Approach for Multiple Sclerosis Treatment

Tahmasebi, Fatemeh, Asl, Elmira Roshani, Vahidinia, Zeinab, Barati, Shirin·2024·Cellular and Molecular Neurobiology
DOI 10.1007/s10571-024-01478-1PMC PMC11076329
Open this paper in CoChat — free account

Abstract

Multiple Sclerosis (MS) is an autoimmune disease of the central nervous system (CNS) characterized by inflammation and demyelination of CNS neurons. Up to now, there are many therapeutic strategies for MS but they are only being able to reduce progression of diseases and have not got any effect on repair and remyelination. Stem cell therapy is an appropriate method for regeneration but has limitations and problems. So recently, researches were used of exosomes that facilitate intercellular communication and transfer cell-to-cell biological information. MicroRNAs (miRNAs) are a class of short non-coding RNAs that we can used to their dysregulation in order to diseases diagnosis. The miRNAs of microvesicles obtained stem cells may change the fate of transplanted cells based on received signals of injured regions. The miRNAs existing in MSCs may be displayed the cell type and their biological activities. Current studies show also that the miRNAs create communication between stem cells and tissue-injured cells. In the present review, firstly we discuss the role of miRNAs dysregulation in MS patients and miRNAs expression by stem cells. Finally, in this study was confirmed the relationship of microRNAs involved in MS and miRNAs expressed by stem cells and interaction between them in order to find appropriate treatment methods in future for limit to disability progression. Graphical Abstract The effect of miRNAs in transplanted MSC derived exosomes for MS patient treatment. The role of different miRNAs on proliferation, reprogramming, migration and differentiation have been shown.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10571-024-01478-1

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Glial cells related miRNA expression in Multiple Sclerosis. MicroRNA are upregulated (red) and downregulated (blue) in microglia, astrocytes, and oligodendrocytes in the nervous system of MS patients
Fig. 1 Glial cells related miRNA expression in Multiple Sclerosis. MicroRNA are upregulated (red) and downregulated (blue) in microglia, astrocytes, and oligodendrocytes in the nervous system of MS patientsCC BY · PubMed Central
Fig. 2 Immune system related miRNA expression in Multiple Sclerosis. MicroRNAs are upregulated (red) and downregulated (blue) in CD4+ T cells, CD8+ T cells, Treg cells, and B cells in the immune cells of MS patients
Fig. 2 Immune system related miRNA expression in Multiple Sclerosis. MicroRNAs are upregulated (red) and downregulated (blue) in CD4+ T cells, CD8+ T cells, Treg cells, and B cells in the immune cells of MS patientsCC BY · PubMed Central
Fig. 3 The effect of miRNAs in transplanted MSC-derived exosomes for MS patient treatment. These extracellular vesicles contain microRNAs and proteins. The role of different miRNAs on proliferation, reprogramming, migration, and differentiation has been shown
Fig. 3 The effect of miRNAs in transplanted MSC-derived exosomes for MS patient treatment. These extracellular vesicles contain microRNAs and proteins. The role of different miRNAs on proliferation, reprogramming, migration, and differentiation has been shownCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 122

  1. Abolghasemi M, Poursaei E, Bornehdeli S, Shanehbandi D, Asadi M, Sadeghzadeh M, Sadeh RN (2021) Exploration of potential circulating micro-RNA as biomarker for Alzheimer’s disease. Meta Gene 30:100968 · DOI
  2. Abolghasemi M, Ali Ashrafi S, Asadi M, Shanehbandi D, Sadigh Etehad S, Poursaei E, Shaafi S (2023) MicroRNAs expression in peripheral blood mononuclear cells of patients with multiple sclerosis propose. Mol Biol Rep 50(1):167–172 · DOI
  3. Agostini M, Tucci P, Steinert JR, Shalom-Feuerstein R, Rouleau M, Aberdam D, Concepcion CP (2011) microRNA-34a regulates neurite outgrowth, spinal morphology, and function. Proc Natl Acad Sci 108(52):21099–21104 · DOI
  4. Amoruso A, Blonda M, Gironi M, Grasso R, Di Francescantonio V, Scaroni F, Avolio C (2020) Immune and central nervous system-related miRNAs expression profiling in monocytes of multiple sclerosis patients. Sci Rep 10(1):6125 · DOI · Paper page
  5. Aquino J, Bolontrade M, Garcia M, Podhajcer O, Mazzolini G (2010) Mesenchymal stem cells as therapeutic tools and gene carriers in liver fibrosis and hepatocellular carcinoma. Gene Ther 17(6):692–708 · DOI
  6. Aranda P, Agirre X, Ballestar E, Andreu EJ, Roman-Gomez J, Prieto I, Esteller M (2009) Epigenetic signatures associated with different levels of differentiation potential in human stem cells. PLoS ONE 4(11):e7809 · DOI
  7. Arora S, Rana R, Chhabra A, Jaiswal A, Rani V (2013) miRNA–transcription factor interactions: a combinatorial regulation of gene expression. Mol Genet Genomics 288:77–87 · DOI
  8. Baecher-Allan C, Kaskow BJ, Weiner HL (2018) Multiple sclerosis: mechanisms and immunotherapy. Neuron 97(4):742–768 · DOI · Paper page
  9. Barati S, Tahmasebi F, Faghihi F (2020) Effects of mesenchymal stem cells transplantation on multiple sclerosis patients. Neuropeptides 84:102095 · DOI
  10. Barwari T, Joshi A, Mayr M (2016) MicroRNAs in cardiovascular disease. J Am Coll Cardiol 68(23):2577–2584 · DOI
  11. Baulina N, Kulakova O, Kiselev I, Osmak G, Popova E, Boyko A, Favorova O (2018) Immune-related miRNA expression patterns in peripheral blood mononuclear cells differ in multiple sclerosis relapse and remission. J Neuroimmunol 317:67–76 · DOI
  12. Blonda M, Amoruso A, Grasso R, Di Francescantonio V, Avolio C (2017) Multiple sclerosis treatments affect monocyte-derived microvesicle production. Front Neurol 8:422 · DOI
  13. Boissart C, Nissan X, Giraud-Triboult K, Peschanski M, Benchoua A (2012) miR-125 potentiates early neural specification of human embryonic stem cells. Development 139(7):1247–1257 · DOI
  14. Buhagiar A, Borg J, Ayers D (2020) Overview of current microRNA biomarker signatures as potential diagnostic tools for leukaemic conditions. Non-Coding RNA Res 5(1):22–26 · DOI
  15. Camussi G, Deregibus MC, Bruno S, Cantaluppi V, Biancone L (2010) Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int 78(9):838–848 · DOI
  16. Caplan A (2009) Why are MSCs therapeutic? New data: new insight. J Pathol: J Pathol Soc Great Britain Ireland 217(2):318–324 · DOI
  17. Carthew RW, Sontheimer EJ (2009) Origins and mechanisms of miRNAs and siRNAs. Cell 136(4):642–655 · DOI
  18. Ceolotto G, Giannella A, Albiero M, Kuppusamy M, Radu C, Simioni P, Iori E (2017) miR-30c-5p regulates macrophage-mediated inflammation and pro-atherosclerosis pathways. Cardiovasc Res 113(13):1627–1638 · DOI
  19. Chavakis E, Dimmeler S (2011) Homing of progenitor cells to ischemic tissues. Antioxid Redox Signal 15(4):967–980 · DOI
  20. Chen C-Z, Li L, Lodish HF, Bartel DP (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science 303(5654):83–86 · DOI · Paper page
  21. Chen TS, Lai RC, Lee MM, Choo ABH, Lee CN, Lim SK (2010) Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs. Nucleic Acids Res 38(1):215–224 · DOI
  22. Cheng L-C, Pastrana E, Tavazoie M, Doetsch F (2009) miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat Neurosci 12(4):399–408 · DOI · Paper page
  23. Choi YJ, Lin C-P, Ho JJ, He X, Okada N, Bu P, Chen C (2011) miR-34 miRNAs provide a barrier for somatic cell reprogramming. Nat Cell Biol 13(11):1353–1360 · DOI
  24. Collino F, Deregibus MC, Bruno S, Sterpone L, Aghemo G, Viltono L, Camussi G (2010) Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS ONE 5(7):e11803 · DOI · Paper page
  25. Crop M, Baan C, Weimar W, Hoogduijn M (2009) Potential of mesenchymal stem cells as immune therapy in solid-organ transplantation. Transpl Int 22(4):365–376 · DOI
  26. Dai J, Su Y, Zhong S, Cong L, Liu B, Yang J, Jiang Y (2020) Exosomes: key players in cancer and potential therapeutic strategy. Signal Trans Target Ther 5(1):145 · DOI · Paper page
  27. De Santis G, Ferracin M, Biondani A, Caniatti L, Tola MR, Castellazzi M, Fainardi E (2010) Altered miRNA expression in T regulatory cells in course of multiple sclerosis. J Neuroimmunol 226(1–2):165–171 · DOI
  28. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. the international society for cellular therapy position statement. Cytotherapy 8:315–317 · DOI · Paper page
  29. Duan Y, Luo Q, Wang Y, Ma Y, Chen F, Zhu X, Shi J (2020) Adipose mesenchymal stem cell-derived extracellular vesicles containing microRNA-26a-5p target TLR4 and protect against diabetic nephropathy. J Biol Chem 295(37):12868–12884 · DOI
  30. Ehya F, Tehrani HA, Garshasbi M, Nabavi SM (2017) Identification of miR-24 and miR-137 as novel candidate multiple sclerosis miRNA biomarkers using multi-staged data analysis protocol. Mol Biol Res Commun 6(3):127
  31. Essandoh K, Li Y, Huo J, Fan G-C (2016) MiRNA-mediated macrophage polarization and its potential role in the regulation of inflammatory response. Shock (augusta, Ga) 46(2):122 · DOI
  32. Fayyad-Kazan H, Hamade E, Rouas R, Najar M, Fayyad-Kazan M, El Zein N, Al-Akoum C (2014) Downregulation of microRNA-24 and-181 parallels the upregulation of IFN-γ secreted by activated human CD4 lymphocytes. Hum Immunol 75(7):677–685 · DOI
  33. Fenoglio C, Ridolfi E, Cantoni C, De Riz M, Bonsi R, Serpente M, Alvarez E (2013) Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis. Mult Scler J 19(14):1938–1942 · DOI
  34. Gallo S, Gili M, Lombardo G, Rossetti A, Rosso A, Dentelli P, Camussi G (2016) Stem cell-derived, microRNA-carrying extracellular vesicles: a novel approach to interfering with mesangial cell collagen production in a hyperglycaemic setting. PLoS ONE 11(9):e0162417 · DOI
  35. Gandhi R, Healy B, Gholipour T, Egorova S, Musallam A, Hussain MS, Khoury S (2013) Circulating microRNAs as biomarkers for disease staging in multiple sclerosis. Ann Neurol 73(6):729–740 · DOI
  36. Gangaraju VK, Lin H (2009) MicroRNAs: key regulators of stem cells. Nat Rev Mol Cell Biol 10(2):116–125 · DOI
  37. Gaudet AD, Fonken LK, Watkins LR, Nelson RJ, Popovich PG (2018) MicroRNAs: roles in regulating neuroinflammation. Neuroscientist 24(3):221–245 · DOI · Paper page
  38. Ghadiri N, Emamnia N, Ganjalikhani-Hakemi M, Ghaedi K, Etemadifar M, Salehi M, Nasr-Esfahani MH (2018) Analysis of the expression of mir-34a, mir-199a, mir-30c and mir-19a in peripheral blood CD4+ T lymphocytes of relapsing-remitting multiple sclerosis patients. Gene 659:109–117 · DOI
  39. Giacalone G, Clarelli F, Osiceanu A, Guaschino C, Brambilla P, Sorosina M, Rodegher M (2015) Analysis of genes, pathways and networks involved in disease severity and age at onset in primary-progressive multiple sclerosis. Mult Scler J 21(11):1431–1442 · DOI
  40. Greco SJ, Rameshwar P (2007) MicroRNAs regulate synthesis of the neurotransmitter substance P in human mesenchymal stem cell-derived neuronal cells. Proc Natl Acad Sci 104(39):15484–15489 · DOI
  41. Greco SJ, Liu K, Rameshwar P (2007) Functional similarities among genes regulated by OCT4 in human mesenchymal and embryonic stem cells. Stem Cells 25(12):3143–3154 · DOI
  42. Guerau-de-Arellano M, Smith KM, Godlewski J, Liu Y, Winger R, Lawler SE, Lovett-Racke AE (2011) Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity. Brain 134(12):3578–3589 · DOI · Paper page
  43. Han X, Fan Z (2021) MicroRNAs regulation in osteogenic differentiation of mesenchymal stem cells. Front Dent Med. https://doi.org/10.3389/fdmed.2021.747068 · DOI
  44. Haney MJ, Klyachko NL, Zhao Y, Gupta R, Plotnikova EG, He Z, Kabanov AV (2015) Exosomes as drug delivery vehicles for Parkinson’s disease therapy. J Control Release 207:18–30 · DOI · Paper page
  45. Hao Y, Miao J, Liu W, Cai K, Huang X, Peng L (2021) Mesenchymal stem cell-derived exosomes carry microRNA-125a to protect against diabetic nephropathy by targeting histone deacetylase 1 and downregulating endothelin-1. Diabet Metabol Syndr Obes: Target Ther 14:1405–1418 · DOI
  46. Hecker M, Thamilarasan M, Koczan D, Schröder I, Flechtner K, Freiesleben S, Zettl UK (2013) MicroRNA expression changes during interferon-beta treatment in the peripheral blood of multiple sclerosis patients. Int J Mol Sci 14(8):16087–16110 · DOI
  47. Heinrich E-M, Dimmeler S (2012) MicroRNAs and stem cells: control of pluripotency, reprogramming, and lineage commitment. Circ Res 110(7):1014–1022 · DOI
  48. Hemmer B, Kerschensteiner M, Korn T (2015) Role of the innate and adaptive immune responses in the course of multiple sclerosis. Lancet Neurol 14(4):406–419 · DOI
  49. Hergenreider E, Heydt S, Tréguer K, Boettger T, Horrevoets AJ, Zeiher AM, Mayr M (2012) Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol 14(3):249–256 · DOI
  50. Hsia L-T, Ashley N, Ouaret D, Wang LM, Wilding J, Bodmer WF (2016) Myofibroblasts are distinguished from activated skin fibroblasts by the expression of AOC3 and other associated markers. Proc Natl Acad Sci 113(15):E2162–E2171 · DOI
  51. Hu R, Li H, Liu W, Yang L, Tan Y-F, Luo X-H (2010) Targeting miRNAs in osteoblast differentiation and bone formation. Expert Opin Ther Targets 14(10):1109–1120 · DOI
  52. Huang F, Zhu X, Hu X-Q, Fang Z-F, Tang L, Lu X-L, Zhou S-H (2013) Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate notch ligand delta-like-4, enhancing ischemic angiogenesis and cell survival. Int J Mol Med 31(2):484–492 · DOI
  53. Humphreys BD, Valerius MT, Kobayashi A, Mugford JW, Soeung S, Duffield JS, Bonventre JV (2008) Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell 2(3):284–291 · DOI · Paper page
  54. Ieda M, Fu J-D, Delgado-Olguin P, Vedantham V, Hayashi Y, Bruneau BG, Srivastava D (2010) Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142(3):375–386 · DOI · Paper page
  55. Jagot F, Davoust N (2016) Is it worth considering circulating microRNAs in multiple sclerosis? Front Immunol 7:129 · DOI · Paper page
  56. Jakob P, Landmesser U (2012) Role of microRNAs in stem/progenitor cells and cardiovascular repair. Cardiovasc Res 93(4):614–622 · DOI
  57. Jernås M, Malmeström C, Axelsson M, Nookaew I, Wadenvik H, Lycke J, Olsson B (2013) MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS). BMC Immunol 14(1):1–11 · DOI
  58. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Blackstad M (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418(6893):41–49 · DOI
  59. Jin J, Shi Y, Gong J, Zhao L, Li Y, He Q, Huang H (2019) Exosome secreted from adipose-derived stem cells attenuates diabetic nephropathy by promoting autophagy flux and inhibiting apoptosis in podocyte. Stem Cell Res Ther 10:1–15 · DOI
  60. Judson RL, Babiarz JE, Venere M, Blelloch R (2009) Embryonic stem cell–specific microRNAs promote induced pluripotency. Nat Biotechnol 27(5):459–461 · DOI
  61. Junker A, Krumbholz M, Eisele S, Mohan H, Augstein F, Bittner R, Meinl E (2009) MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain 132(12):3342–3352 · DOI · Paper page
  62. Kacperska MJ, Jastrzebski K, Tomasik B, Walenczak J, Konarska-Krol M, Glabinski A (2015) Selected extracellular microRNA as potential biomarkers of multiple sclerosis activity—preliminary study. J Mol Neurosci 56:154–163 · DOI
  63. Kim H, Lee G, Ganat Y, Papapetrou EP, Lipchina I, Socci ND, Studer L (2011) miR-371-3 expression predicts neural differentiation propensity in human pluripotent stem cells. Cell Stem Cell 8(6):695–706 · DOI
  64. Kimura K, Hohjoh H, Fukuoka M, Sato W, Oki S, Tomi C, Yamamura T (2018) Circulating exosomes suppress the induction of regulatory T cells via let-7i in multiple sclerosis. Nat Commun 9(1):17 · DOI
  65. Lakshmipathy U, Hart RP (2008) Concise review: microRNA expression in multipotent mesenchymal stromal cells. Stem Cells 26(2):356–363 · DOI
  66. Leri A, Kajstura J, Anversa P (2011) Role of cardiac stem cells in cardiac pathophysiology: a paradigm shift in human myocardial biology. Circ Res 109(8):941–961 · DOI
  67. Li Z, Yang CS, Nakashima K, Rana TM (2011) Small RNA-mediated regulation of iPS cell generation. EMBO J 30(5):823–834 · DOI
  68. Liang X, Zhang L, Wang S, Han Q, Zhao RC (2016) Exosomes secreted by mesenchymal stem cells promote endothelial cell angiogenesis by transferring miR-125a. J Cell Sci 129(11):2182–2189 · DOI
  69. Lindberg RL, Hoffmann F, Mehling M, Kuhle J, Kappos L (2010) Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing–remitting multiple sclerosis patients. Eur J Immunol 40(3):888–898 · DOI
  70. Liu C, Teng Z-Q, Santistevan NJ, Szulwach KE, Guo W, Jin P, Zhao X (2010) Epigenetic regulation of miR-184 by MBD1 governs neural stem cell proliferation and differentiation. Cell Stem Cell 6(5):433–444 · DOI
  71. Liu J, Wang L, Su Z, Wu W, Cai X, Li D, Pan G (2014) A reciprocal antagonism between miR-376c and TGF-β signaling regulates neural differentiation of human pluripotent stem cells. FASEB J 28(11):4642–4656 · DOI
  72. Ma X, Zhou J, Zhong Y, Jiang L, Mu P, Li Y, Nagarkatti P (2014) Expression, regulation and function of microRNAs in multiple sclerosis. Int J Med Sci 11(8):810 · DOI
  73. Mao R, Shen J, Hu X (2020) BMSCs-derived exosomal microRNA-let-7a plays a protective role in diabetic nephropathy via inhibition of USP22 expression. Life Sci 268:118937–118937 · DOI
  74. Meoli EM, Oh U, Grant CW, Jacobson S (2011) TGF-β signaling is altered in the peripheral blood of subjects with multiple sclerosis. J Neuroimmunol 230(1–2):164–168 · DOI
  75. Mizuno Y, Yagi K, Tokuzawa Y, Kanesaki-Yatsuka Y, Suda T, Katagiri T, Amemiya T (2008) miR-125b inhibits osteoblastic differentiation by down-regulation of cell proliferation. Biochem Biophys Res Commun 368(2):267–272 · DOI
  76. Mohammed EM (2020) Environmental influencers, microRNA, and multiple sclerosis. J Cent Nerv Sys Dis 12:1179573519894955 · DOI
  77. O’Rourke JR, Georges SA, Seay HR, Tapscott SJ, McManus MT, Goldhamer DJ, Harfe BD (2007) Essential role for Dicer during skeletal muscle development. Dev Biol 311(2):359–368 · DOI
  78. Pauley KM, Cha S, Chan EK (2009) MicroRNA in autoimmunity and autoimmune diseases. J Autoimmun 32(3–4):189–194 · DOI
  79. Peng L, Chen Y, Shi S, Wen H (2022) Stem cell-derived and circulating exosomal microRNAs as new potential tools for diabetic nephropathy management. Stem Cell Res Ther 13(1):25 · DOI
  80. Peter ME (2009) Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. Cell Cycle 8(6):843–852 · DOI
  81. Phinney DG, Prockop DJ (2007) Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair—current views. Stem Cells 25(11):2896–2902 · DOI
  82. Pöllinger B (2012) IL-17 producing T cells in mouse models of multiple sclerosis and rheumatoid arthritis. J Mol Med 90:613–624 · DOI
  83. Ponomarev ED, Veremeyko T, Weiner HL (2013) MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNS. Glia 61(1):91–103 · DOI · Paper page
  84. Raposo G, Stoorvogel W (2013) Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 200(4):373–383 · DOI · Paper page
  85. Rosa A, Brivanlou AH (2011) A regulatory circuitry comprised of miR-302 and the transcription factors OCT4 and NR2F2 regulates human embryonic stem cell differentiation. EMBO J 30(2):237–248 · DOI · Paper page
  86. Rustad KC, Gurtner GC (2012) Mesenchymal stem cells home to sites of injury and inflammation. Adv Wound Care 1(4):147–152 · DOI
  87. Schratt GM, Tuebing F, Nigh EA, Kane CG, Sabatini ME, Kiebler M, Greenberg ME (2006) A brain-specific microRNA regulates dendritic spine development. Nature 439(7074):283–289 · DOI · Paper page
  88. Shah A, Meese E, Blin N (2010) Profiling of regulatory microRNA transcriptomes in various biological processes: a review. J Appl Genet 51:501–507 · DOI
  89. Siegel SR, Mackenzie J, Chaplin G, Jablonski NG, Griffiths L (2012) Circulating microRNAs involved in multiple sclerosis. Mol Biol Rep 39:6219–6225 · DOI
  90. Sievers C, Meira M, Hoffmann F, Fontoura P, Kappos L, Lindberg RL (2012) Altered microRNA expression in B lymphocytes in multiple sclerosis: towards a better understanding of treatment effects. Clin Immunol 144(1):70–79 · DOI
  91. Smalheiser NR (2007) Exosomal transfer of proteins and RNAs at synapses in the nervous system. Biol Direct 2(1):1–15 · DOI
  92. Smith KM, Guerau-de-Arellano M, Costinean S, Williams JL, Bottoni A, Mavrikis Cox G, Lovett-Racke AE (2012) miR-29ab1 deficiency identifies a negative feedback loop controlling Th1 bias that is dysregulated in multiple sclerosis. J Immunol 189(4):1567–1576 · DOI
  93. Søndergaard HB, Hesse D, Krakauer M, Sørensen PS, Sellebjerg F (2013) Differential microRNA expression in blood in multiple sclerosis. Mult Scler J 19(14):1849–1857 · DOI
  94. Sospedra, M., & Martin, R. (2016). Immunology of multiple sclerosis. Paper presented at the Seminars in neurology. · DOI
  95. Stampanoni Bassi M, Iezzi E, Buttari F, Gilio L, Simonelli I, Carbone F, Furlan R (2020) Obesity worsens central inflammation and disability in multiple sclerosis. Mult Scler J 26(10):1237–1246 · DOI
  96. Subramanyam D, Lamouille S, Judson RL, Liu JY, Bucay N, Derynck R, Blelloch R (2011) Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells. Nat Biotechnol 29(5):443–448 · DOI
  97. Sun J, Zhao F, Zhang W, Lv J, Lv J, Yin A (2018) BMSC s and miR-124a ameliorated diabetic nephropathy via inhibiting notch signalling pathway. J Cell Mol Med 22(10):4840–4855 · DOI
  98. Suzuki Y, Kim HW, Ashraf M, Haider HK (2010) Diazoxide potentiates mesenchymal stem cell survival via NF-κB-dependent miR-146a expression by targeting Fas. Am J Physiol-Heart Circ Physiol 299(4):H1077–H1082 · DOI
  99. Tahmasebi F, Barati S (2023) The role of microglial depletion approaches in pathological condition of CNS. Cell Mol Neurobiol. https://doi.org/10.1007/s10571-023-01326-8 · DOI
  100. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663–676 · DOI · Paper page
  101. Tarassishin L, Loudig O, Bauman A, Shafit-Zagardo B, Suh HS, Lee SC (2011) Interferon regulatory factor 3 inhibits astrocyte inflammatory gene expression through suppression of the proinflammatory miR-155 and miR-155. Glia 59(12):1911–1922 · DOI
  102. Tata PR, Tata NR, Kühl M, Sirbu IO (2011) Identification of a novel epigenetic regulatory region within the pluripotency associated microRNA cluster. EEmiRC Nucleic Acids Res 39(9):3574–3581 · DOI
  103. Tay YM-S, Tam W-L, Ang Y-S, Gaughwin PM, Yang H, Wang W, Perera RJ (2008) MicroRNA-134 modulates the differentiation of mouse embryonic stem cells, where it causes post-transcriptional attenuation of Nanog and LRH1. Stem Cells 26(1):17–29 · DOI
  104. Tsai MS, Hwang SM, Chen KD, Lee YS, Hsu LW, Chang YJ, Chao AS (2007) Functional network analysis of the transcriptomes of mesenchymal stem cells derived from amniotic fluid, amniotic membrane, cord blood, and bone marrow. Stem Cells 25(10):2511–2523 · DOI
  105. Viñas JL, Spence M, Gutsol A, Knoll W, Burger D, Zimpelmann J, Burns KD (2018) Receptor-ligand interaction mediates targeting of endothelial colony forming cell-derived exosomes to the kidney after ischemic injury. Sci Rep 8(1):16320 · DOI
  106. Viswanathan SR, Daley GQ, Gregory RI (2008) Selective blockade of microRNA processing by Lin28. Science 320(5872):97–100 · DOI
  107. Wang J, Park JW, Drissi H, Wang X, Xu R-H (2014) Epigenetic regulation of miR-302 by JMJD1C inhibits neural differentiation of human embryonic stem cells. J Biol Chem 289(4):2384–2395 · DOI
  108. Wang B, Yao K, Huuskes BM, Shen H-H, Zhuang J, Godson C, Ricardo SD (2016a) Mesenchymal stem cells deliver exogenous microRNA-let7c via exosomes to attenuate renal fibrosis. Mol Ther 24(7):1290–1301 · DOI
  109. Wang H, Ye Y, Zhu Z, Mo L, Lin C, Wang Q, Lu G (2016b) MiR-124 regulates apoptosis and autophagy process in MPTP model of Parkinson’s disease by targeting to B im. Brain Pathol 26(2):167–176 · DOI · Paper page
  110. Waschbisch A, Atiya M, Linker RA, Potapov S, Schwab S, Derfuss T (2011) Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis. PLoS ONE 6(9):e24604 · DOI
  111. Wei W, Ao Q, Wang X, Cao Y, Liu Y, Zheng SG, Tian X (2021) Mesenchymal stem cell-derived exosomes: a promising biological tool in nanomedicine. Front Pharmacol 11:590470 · DOI
  112. Xu N, Papagiannakopoulos T, Pan G, Thomson JA, Kosik KS (2009) MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 137(4):647–658 · DOI
  113. Xu Q, Seeger FH, Castillo J, Iekushi K, Boon RA, Farcas R, Zeiher AM (2012) Micro-RNA-34a contributes to the impaired function of bone marrow-derived mononuclear cells from patients with cardiovascular disease. J Am Coll Cardiol 59(23):2107–2117 · DOI
  114. Xu Z, Dong D, Chen X, Huang H, Wen S (2015) MicroRNA-381 negatively regulates TLR4 signaling in A549 cells in response to LPS stimulation. BioMed Res Int. https://doi.org/10.1155/2015/849475 · DOI
  115. Yaldizli Ö, Putzki N (2009) Natalizumab in the treatment of multiple sclerosis. Ther Adv Neurol Disord 2(2):115–128 · DOI
  116. Yang D, Li T, Wang Y, Tang Y, Cui H, Tang Y, Le W (2012) miR-132 regulates the differentiation of dopamine neurons by directly targeting Nurr1 expression. J Cell Sci 125(7):1673–1682
  117. Yang D, Wang W-Z, Zhang X-M, Yue H, Li B, Lin L, Fu J (2014) MicroRNA expression aberration in Chinese patients with relapsing remitting multiple sclerosis. J Mol Neurosci 52:131–137 · DOI
  118. Yoo AS, Staahl BT, Chen L, Crabtree GR (2009) MicroRNA-mediated switching of chromatin-remodelling complexes in neural development. Nature 460(7255):642–646 · DOI · Paper page
  119. Zhang J, Cheng Y, Cui W, Li M, Li B, Guo L (2014) MicroRNA-155 modulates Th1 and Th17 cell differentiation and is associated with multiple sclerosis and experimental autoimmune encephalomyelitis. J Neuroimmunol 266(1–2):56–63 · DOI
  120. Zhao C, Sun G, Li S, Shi Y (2009) A feedback regulatory loop involving microRNA-9 and nuclear receptor TLX in neural stem cell fate determination. Nat Struct Mol Biol 16(4):365–371 · DOI · Paper page
  121. Zhao T, Sun F, Liu J, Ding T, She J, Mao F, Yan Y (2019) Emerging role of mesenchymal stem cell-derived exosomes in regenerative medicine. Curr Stem Cell Res Ther 14(6):482–494 · DOI
  122. Zhu S, Pan W, Song X, Liu Y, Shao X, Tang Y, Liu W (2012) The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α. Nat Med 18(7):1077–1086 · DOI · Paper page

Cited by

Sorted by citations

See all 6

Metadata

Authors
Tahmasebi, F., Asl, E. R., Vahidinia, Z., & Barati, S.
Venue
Cellular and Molecular Neurobiology
Publisher
Springer Science and Business Media LLC
Published
2024-05-07
Volume
44
Issue
1
ISSN
  • 0272-4340
  • 1573-6830
DOI
10.1007/s10571-024-01478-1
PMC
PMC11076329
Cited by
6
References
12
Language
en
Licence
Funders
saveh university of medical sciences

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review